PipelinePharma Logo

Generics 92

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Cefepime manufacturers

92 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

92 products found

cefepime

Injection 1 gm

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19740
This pharmaceutical company, established in 2005, offers a range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They focus on key therapy areas such as hepatology and pain management, delivering these through various dosage forms like syrups, tablets, injections, capsules, and ointments. Operating across North America, the EU, and other regions, this company is WHO-GMP and ISO 9001-2015 certified. They have a strong track record of success, evidenced by their partnerships with leading pharmaceutical companies and awards recognizing their commitment to quality.

cefepime + tazobactam sodium

Injection 1 g+125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19464
This company is a leading generic pharmaceutical manufacturer with over six decades of experience. They produce a wide range of products, including prescription medications, over-the-counter drugs, injectables, liquids, and external preparations. Their therapeutic areas include antibiotics, anti-diabetics, anti-malarials, NSAIDs, cardiology medications, central nervous system drugs, gastrointestinal agents, hormones, respiratory/anti-allergic medications, urology/infertility treatments, and health supplements. The company holds various certifications including ISO 9001, ISO 15378, GMP, WHO-GMP, and FSSAI. They export their products to over 30 countries across the globe, with a significant portion of their turnover coming from international operations. They emphasize quality assurance through rigorous testing and analysis at various stages of product development and manufacturing.

Manufacturer usually replies in 11 days

cefepime

Injection 1 g, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19464
This company is a leading generic pharmaceutical manufacturer with over six decades of experience. They produce a wide range of products, including prescription medications, over-the-counter drugs, injectables, liquids, and external preparations. Their therapeutic areas include antibiotics, anti-diabetics, anti-malarials, NSAIDs, cardiology medications, central nervous system drugs, gastrointestinal agents, hormones, respiratory/anti-allergic medications, urology/infertility treatments, and health supplements. The company holds various certifications including ISO 9001, ISO 15378, GMP, WHO-GMP, and FSSAI. They export their products to over 30 countries across the globe, with a significant portion of their turnover coming from international operations. They emphasize quality assurance through rigorous testing and analysis at various stages of product development and manufacturing.

Manufacturer usually replies in 11 days

Want to see all 92 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions. The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical. Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.